×
× KTN KTN News KTN Morning Express KTN Leo Leo Mashinani The Big Story Checkpoint News Center E-Paper Lifestyle & Entertainment Nairobian Entertainment Eve Woman Travelog TV Stations KTN Home KTN News BTV KTN Farmers TV Radio Stations Radio Maisha Spice FM Vybez Radio Enterprise VAS E-Learning Digger Classified Jobs Games Crosswords Sudoku The Standard Group Corporate Contact Us Rate Card Vacancies DCX O.M Portal Corporate Email RMS
Login
×
Show Swahili

Pfizer and Biontech begin clinical trials of a new Covid vaccine targeting the Omicron variant

26th January, 2022

Pfizer and Biontech have begun clinical trials of a new Covid vaccine – which specifically targets the omicron variant.

The trials will be conducted as a new vaccine and booster jabs on around 1 thousand 4 hundred people. There could be some allergic reactions expected.

.
RELATED VIDEOS